Regavirumab

Regavirumab
Monoclonal antibody
Type	Whole antibody
Source	Human
Target	cytomegalovirus glycoprotein B
Clinical data
ATC code	none;
Identifiers
CAS Number	153101-26-9 ;
ChemSpider	none;
UNII	STG2Q92FWF;
KEGG	D09852;
	(what is this?) (verify)

Regavirumab is a human monoclonal antibody against infections with cytomegalovirus.[1]

References

Arizono H, Sugano T, Kaida S, Shibusawa K, Karasawa Y, Esumi Y, et al. (July 1994). "Pharmacokinetics of a new human monoclonal antibody against cytomegalovirus. Third communication: correspondence of the idiotype activity and virus neutralization activity of the new monoclonal antibody, regavirumab in rat serum and its pharmacokinetics in rats and monkeys". Arzneimittel-Forschung. 44 (7): 909–13. PMID 7945531.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.